Olon Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is TIMOLOL MALEATE, with a corresponding US DMF Number 6644.
Remarkably, this DMF maintains an Active status since its submission on September 10, 1986, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 16, 2014, and payment made on June 09, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II